You are here:Home-Chemical Inhibitors & Agonists-JAK/STAT Signaling-STAT-W1046
W1046

Chemical Structure : W1046

CAS No.: 2816059-41-1

W1046 (W 1046)

Catalog No.: PC-20066Not For Human Use, Lab Use Only.

W1046 is a potent and selective STAT3 inhibitor, decreases the expression of VISTA at mRNA and protein level and inhibits proliferation and survival in AML cells.

Packing Price Stock Quantity
10 mg Get quote
25 mg Get quote
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

    Biological Activity

    W1046 is a potent and selective STAT3 inhibitor, decreases the expression of VISTA at mRNA and protein level and inhibits proliferation and survival in AML cells.
    W1046 occupied the pivotal core of SH2 domain and elevated thermal stability of STAT3 protein.
    W1046 significantly decreased the expression of VISTA at mRNA and protein level in AML cells.
    W1046 significantly inhibited AML cells with hyperactive STAT3 (MOLM-13, IC50=1.85 uM) but was lacked of sensitivity in MCF-7 cells with low STAT3 activation (IC50>15 uM) and in MOLM-13 cells with STAT3 deletion by CRISPR-Cas9.
    W1046 displayed no or slight effect on the phosphorylation of STAT1, STAT5, and upstream kinase JAK2.
    W1046 significantly inhibited proliferation and induced apoptosis both in AML cells lines and in primary AML patient samples.
    W1046 remarkedly suppressed leukemia aggression, reduced leukemia burden and prolonged the survival of leukemia mice dosage-dependently.
    Combination of VISTA mAb and STAT3 inhibitor displayed potent anti-leukemia effect in xenograft mouse models with MOLM-13-EGFP/Luc cells.

    Physicochemical Properties

    M.Wt 610.40
    Formula C28H28BF5N2O5S
    Appearance Solid
    CAS No.
    Storage
    Solide Powder
    -20°C 12 Months; 4°C 6 Months
    In Solvent
    -80°C 6 Months; -20°C 6 Months
    Shipping
    Solubility

    10 mM in DMSO

    Chemical Name/SMILES

    (4-(N-(4-cyclohexylbenzyl)-2-((2,3,4,5,6-pentafluoro-N-methylphenyl)sulfonamido)acetamido)phenyl)boronic acid

    References

    1. Mo J, et al. J Hematol Oncol. 2023 Feb 27;16(1):15.

    2. Deng L, et al. Boronic acid: a novel pharmacophore targeting src homology 2 (SH2) domain of STAT3. J Med Chem, 2022.

    Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    Contact Us sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    Get Quote

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • Additional Information: